NEW YORK (GenomeWeb News) – Bruker has priced a secondary offering of 13 million common shares at $9.85 per share.

The firm announced last week that it had filed for a secondary offering of 12 million shares of common stock by two members of the Laukien family — Marc Laukien and Isolde Laukien-Kleiner — not involved in the firm's business. Bruker will not receive any of the proceeds from the sale of shares by these two Laukien family members.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.